Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study.

Shahin, Ahmad; Janeczek, Monica; Butterfield, Richard; Bhullar, Puneet; Boudreaux, Blake; Ho, Thai; Mangold, Aaron

Shahin, Ahmad; Janeczek, Monica; Butterfield, Richard; Bhullar, Puneet; Boudreaux, Blake; Ho, Thai; Mangold, Aaron.

Afiliación

Shahin A; Mayo Clinic Alix School of Medicine, Scottsdale, Arizona.
Janeczek M; Department of Dermatology, Mayo Clinic, Scottsdale, Arizona.
Butterfield R; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona.
Bhullar P; Mayo Clinic Alix School of Medicine, Scottsdale, Arizona.
Boudreaux B; Department of Dermatology, Mayo Clinic, Scottsdale, Arizona.
Ho T; Department of Dermatology, Mayo Clinic, Scottsdale, Arizona.
Mangold A; Division of Medical Oncology, Mayo Clinic, Phoenix, Arizona.

JAAD Int ; 10: 46-47, 2023 Mar.

Article en En | MEDLINE | ID: mdl-36457993

Palabras clave

drug eruption; drug reaction; enfortumab vedotin; medical dermatology; oncologic therapy; oncology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAAD Int Año: 2023 Tipo del documento: Article